RE: Efficacy and Safety of Mirabegron Add-On Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-Blind Multicentre Phase 3B Study (Beside)

AuthID
 P-00M-54P
1
Author(s)
Tipo de Documento
Editorial Material
Year published
2016
Publicado
in EUROPEAN UROLOGY, ISSN: 0302-2838
Volume: 70, Número: 5, Páginas: 892-892 (1)
Indexing
Wos®
Scopus®
Crossref®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 27567206
SCOPUS: 2-s2.0-84994300338
Wos: WOS:000385515600038
Source Identifiers
ISSN: 0302-2838
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service